# Dualyx NV

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dualyx

- Industry: Biotechnology
- Headquarters: Ghent, Belgium
- Website: www.dualyx.com
- Total disclosed funding: $35M
- Latest round: Series A (May 8, 2023)
- Investors on record: 10

## About

Based in Zwijnaarde, Belgium, and founded in 2020 by CSO Luc van Rompaey with Wurzburg University, Argenx, VIB, Ghent University, and KU Leuven, Dualyx NV operates as a biotechnology company providing Treg-based therapies to support the patients with difficult-to-treat autoimmune diseases. In May 2023, Dualyx NV raised EUR 40 million in Series A funding led by Fountain Healthcare Partners, with participation from Andera Partners, Forbion, BioGeneration Ventures, High-Tech Gründerfonds, and K.U. Leuven Research & Development, PMV, V-Bio Ventures, and VIB also participated in the round.

Dualyx NV developed immune modulators for identifying the in vivo expansion of regulatory T cells. The company’s technology allows users to improve and activate potent Treg cells can restore the ratio of regulatory to effector T cells and suppress the unwanted autoimmune reaction to achieve long-lasting or even curative treatments in autoimmune disease patients. In addition, the firm provides DT-001 which is a program for modulating the validated immune suppression target TNF receptor 2.

## Funding rounds

- Series A, May 8, 2023, $28M — K.U. Leuven Research & Development, Andera Partners, Forbion, BioGeneration Ventures, Fountain Healthcare Partners, PMV, High-Tech Gruenderfonds, VIB, V-Bio Ventures
- Seed, Apr 10, 2020, $7.7M — K.U. Leuven Research & Development, BioGeneration Ventures, PMV, High-Tech Gruenderfonds, VIB, V-Bio Ventures, Participatiemaatschappij Vlaanderen NV

## Investors

- K.U. Leuven Research & Development (https://capitalatlas.ai/funds/k-u-leuven-research-development) — Seed, Series A
- BioGeneration Ventures (https://capitalatlas.ai/funds/biogeneration-ventures) — Seed, Series A
- PMV (https://capitalatlas.ai/funds/pmv) — Seed, Series A
- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed, Series A
- VIB — Seed, Series A
- V-Bio Ventures (https://capitalatlas.ai/funds/v-bio-ventures) — Seed, Series A
- Participatiemaatschappij Vlaanderen NV — Seed
- Andera Partners (https://capitalatlas.ai/funds/andera-partners) — Series A
- Forbion (https://capitalatlas.ai/funds/forbion) — Series A
- Fountain Healthcare Partners (https://capitalatlas.ai/funds/fountain-healthcare-partners) — Series A